Search Results Search Sort by RelevanceMost Recent Personal Narrative Jul 2002 Through the Patient's Eyes: Paying Interest on Borrowed Time Stephen Foster, MD A patient reflects on his past medical care and his desire to give back to society by volunteering in a clinical research study. Virtual Mentor. 2002;4(7):214-215. doi: 10.1001/virtualmentor.2002.4.7.prsp1-0207. Viewpoint Jul 2002 The Dangers of Summer Colleen Danz Statistics and facts about summertime accidents, injuries, and deaths. Virtual Mentor. 2002;4(7):209-210. doi: 10.1001/virtualmentor.2002.4.7.dykn1-0207. Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562. Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551. History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580. Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527. AMA Code Says Jan 2002 The Use of DNA Databanks in Genomic Research Faith Lagay, PhD The AMA's Code of Medical Ethics' opinion on the use of databanks in genomic research requires informed consent by groups and individuals who are subjects of research. Virtual Mentor. 2002;4(1):15-18. doi: 10.1001/virtualmentor.2002.4.1.code1-0201. Pagination First page « First Previous page ‹ Previous … Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Current page 24
Personal Narrative Jul 2002 Through the Patient's Eyes: Paying Interest on Borrowed Time Stephen Foster, MD A patient reflects on his past medical care and his desire to give back to society by volunteering in a clinical research study. Virtual Mentor. 2002;4(7):214-215. doi: 10.1001/virtualmentor.2002.4.7.prsp1-0207.
Viewpoint Jul 2002 The Dangers of Summer Colleen Danz Statistics and facts about summertime accidents, injuries, and deaths. Virtual Mentor. 2002;4(7):209-210. doi: 10.1001/virtualmentor.2002.4.7.dykn1-0207.
Medicine and Society Jul 2024 How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities. AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
Policy Forum Jul 2024 How Should the Use of Opioids Be Regulated to Motivate Better Clinical Practice? Ellen L. Edens, MD, MPE, MA, Gabriela Garcia Vassallo, MD, and Robert Heimer, PhD Reconsider regulatory and clinical frameworks for prescribing long-term opioid therapy for pain and prescribing opioids to treat OUD. AMA J Ethics. 2024;26(7):E551-561. doi: 10.1001/amajethics.2024.551.
History of Medicine Jul 2024 Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions. AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580.
Case and Commentary Jul 2024 When Are “Paraphernalia” Critical Medical Supplies? Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality. AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527.
AMA Code Says Jan 2002 The Use of DNA Databanks in Genomic Research Faith Lagay, PhD The AMA's Code of Medical Ethics' opinion on the use of databanks in genomic research requires informed consent by groups and individuals who are subjects of research. Virtual Mentor. 2002;4(1):15-18. doi: 10.1001/virtualmentor.2002.4.1.code1-0201.